ID   SK-MEL-8
AC   CVCL_6960
SY   SK-Mel-8; AD-Mel
DR   Wikidata; Q54954320
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=978138;
RX   PubMed=1067619;
RX   PubMed=3518877;
RX   PubMed=22970293;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 16
//
RX   DOI=10.1007/978-1-4615-7228-2_39;
RA   Houghton A.N., Oettgen H.F., Old L.J.;
RT   "Malignant melanoma. Current status of the search for melanoma-specific
RT   antigens.";
RL   (In) Immunodermatology. Comprehensive Immunology, Vol 7; Safai B., Good R.A. (eds.); pp.557-576; Springer; Boston (1981).
//
RX   PubMed=327080; DOI=10.1093/jnci/59.1.221;
RA   Fogh J., Fogh J.M., Orfeo T.;
RT   "One hundred and twenty-seven cultured human tumor cell lines
RT   producing tumors in nude mice.";
RL   J. Natl. Cancer Inst. 59:221-226(1977).
//
RX   PubMed=833871; DOI=10.1093/jnci/58.2.209;
RA   Fogh J., Wright W.C., Loveless J.D.;
RT   "Absence of HeLa cell contamination in 169 cell lines derived from
RT   human tumors.";
RL   J. Natl. Cancer Inst. 58:209-214(1977).
//
RX   PubMed=978138; DOI=10.1084/jem.144.4.873;
RA   Shiku H., Takahashi T., Oettgen H.F., Old L.J.;
RT   "Cell surface antigens of human malignant melanoma. II. Serological
RT   typing with immune adherence assays and definition of two new surface
RT   antigens.";
RL   J. Exp. Med. 144:873-881(1976).
//
RX   PubMed=1067619; DOI=10.1073/pnas.73.9.3278;
RA   Carey T.E., Takahashi T., Resnick-Silverman L.A., Oettgen H.F.,
RA   Old L.J.;
RT   "Cell surface antigens of human malignant melanoma: mixed
RT   hemadsorption assays for humoral immunity to cultured autologous
RT   melanoma cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 73:3278-3282(1976).
//
RX   PubMed=3518877; DOI=10.3109/07357908609038260;
RA   Fogh J.;
RT   "Human tumor lines for cancer research.";
RL   Cancer Invest. 4:157-184(1986).
//
RX   PubMed=22970293; DOI=10.1371/journal.pone.0044707;
RA   Zhao R.Y., Mifsud N.A., Xiao K., Chan K.-F., Oveissi S., Jackson H.M.,
RA   Dimopoulos N., Guillaume P., Knights A.J., Lowen T., Robson N.C.,
RA   Russell S.E., Scotet E., Davis I.D., Maraskovsky E., Cebon J.S.,
RA   Luescher I.F., Chen W.-S.;
RT   "A novel HLA-B18 restricted CD8+ T cell epitope is efficiently
RT   cross-presented by dendritic cells from soluble tumor antigen.";
RL   PLoS ONE 7:E44707-E44707(2012).
//